Clinical trials: Hereditary Transthyretin Amyloidosis With Polyneuropthy
Hereditary Transthyretin Amyloidosis With Polyneuropthy
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
This is a prospective, non-interventional, Long-term, multinational cohort safety study of patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (hATTR-PN).
- Trial name
- NCT04850105
- Testing
- Data Collection
- Where
- 26 sites in Bulgaria, Cyprus and 6 more
- Volunteers
- 202 people
- Sponsor
- Akcea Therapeutics
Hereditary Transthyretin Amyloidosis With Polyneuropthy
A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN
The objective of the study was to characterize adverse events (AEs) occurring within one day of TEGSEDI administration to adult participants with hATTR-PN overall and in individual participants with respect to time course of AE…
- Trial name
- NCT04306510
- Testing
- TEGSEDI
- Where
- 2 sites in United States, Canada
- Volunteers
- 8 people
- Sponsor
- Akcea Therapeutics